Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

A pharmacy medication alert system based on renal function in older patients.

Geerts AF, Scherpbier-de Haan ND, de Koning FH, van der Sterren TM, van Weel C, Vervoort GM, de Smet PA, de Grauw WJ.

Br J Gen Pract. 2012 Aug;62(601):e525-9. doi: 10.3399/bjgp12X653561.

2.

Medicines optimisation in primary care: can community pharmacies deliver?

De Simoni A, Mullis R, Clyne W, Blenkinsopp A.

Br J Gen Pract. 2012 Aug;62(601):398-9. doi: 10.3399/bjgp12X653444. No abstract available.

3.

Medication review and patient counselling at discharge from the hospital by community pharmacists.

Hugtenburg JG, Borgsteede SD, Beckeringh JJ.

Pharm World Sci. 2009 Dec;31(6):630-7. doi: 10.1007/s11096-009-9314-z. Epub 2009 Aug 1.

PMID:
19649720
4.

Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients.

Geerts AF, De Koning FH, De Vooght KM, Egberts AC, De Smet PA, van Solinge WW.

J Clin Pharm Ther. 2013 Oct;38(5):416-22. doi: 10.1111/jcpt.12081. Epub 2013 Jun 28.

PMID:
23808548
5.

Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) program.

Bhardwaja B, Carroll NM, Raebel MA, Chester EA, Korner EJ, Rocho BE, Brand DW, Magid DJ.

Pharmacotherapy. 2011 Apr;31(4):346-56. doi: 10.1592/phco.31.4.346.

PMID:
21449624
6.

Community pharmacist intervention in patients with renal impairment.

Pourrat X, Sipert AS, Gatault P, Sautenet B, Hay N, Guinard F, Guegan F, Halimi JM.

Int J Clin Pharm. 2015 Dec;37(6):1172-9. doi: 10.1007/s11096-015-0182-4. Epub 2015 Sep 18.

PMID:
26385098
7.

[Development of a clinical decision support system using clinical laboratory test data].

Matsumura Y.

Rinsho Byori. 2011 May;59(5):512-8. Japanese.

PMID:
21706868
8.

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.

PMID:
14871059
9.

Management of hypertension in patients with CKD: differences between primary and tertiary care settings.

Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, Arfè G, Boschi G, Brancati C, Iaccarino P, Conte G.

Am J Kidney Dis. 2005 Jul;46(1):18-25.

PMID:
15983953
10.

The care for chronic heart failure by general practitioners. Results from a clinical audit in Italy.

Cancian M, Battaggia A, Celebrano M, Del Zotti F, Novelletto BF, Michieli R, Saugo M, Pellizzari M, Toffanin R.

Eur J Gen Pract. 2013 Mar;19(1):3-10. doi: 10.3109/13814788.2012.717925. Epub 2012 Sep 24.

PMID:
22998169
11.

Patients' satisfaction with information and experiences with counseling on cardiovascular medication received at the pharmacy.

van Geffen EC, Philbert D, van Boheemen C, van Dijk L, Bos MB, Bouvy ML.

Patient Educ Couns. 2011 Jun;83(3):303-9. doi: 10.1016/j.pec.2011.04.004. Epub 2011 May 6.

12.

Randomized trial to improve prescribing safety in ambulatory elderly patients.

Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW, Magid DJ.

J Am Geriatr Soc. 2007 Jul;55(7):977-85.

PMID:
17608868
13.

Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review.

Stuijt CC, Franssen EJ, Egberts AC, Hudson SA.

Drugs Aging. 2008;25(11):947-54. doi: 10.2165/0002512-200825110-00005.

PMID:
18947262
14.

Prescription data improve the medication history in primary care.

Glintborg B, Andersen SK, Poulsen HE.

Qual Saf Health Care. 2010 Jun;19(3):164-8. doi: 10.1136/qshc.2008.029488. Epub 2010 Mar 1.

PMID:
20194218
15.

Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review.

Stemer G, Lemmens-Gruber R.

BMC Nephrol. 2011 Jul 22;12:35. doi: 10.1186/1471-2369-12-35. Review.

16.

Pharmaceutical care research and education project: pharmacists' interventions.

Kassam R, Farris KB, Burback L, Volume CI, Cox CE, Cave A.

J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):401-10.

PMID:
11372905
17.
18.

Pharmacy Distribution of Advice, Symptomatic Treatment and Antimicrobial Drugs to Patients with Cough.

Cadore LP, da Silva Marc C, Berti C, Peukert C, Machado AR.

Braz J Infect Dis. 1999 Oct;3(5):180-183.

PMID:
11084665
19.

Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice.

van der Meer V, Wielders HP, Grootendorst DC, de Kanter JS, Sijpkens YW, Assendelft WJ, Gussekloo J, Dekker FW, Groeneveld Y.

Br J Gen Pract. 2010 Dec;60(581):884-90. doi: 10.3399/bjgp10X544041.

20.

Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.

LaMarr B, Valdez C, Driscoll K, Ryan M.

Am J Health Syst Pharm. 2010 Feb 15;67(4):290-4. doi: 10.2146/ajhp090009.

PMID:
20133534

Supplemental Content

Support Center